References
- Wigand R, Sabin AB. Properties of ECHO types 22, 23 and 24 viruses. Arch Gesamte Virusforsch. 1961;11:224–247.
- Itta KC, Ghargi KV, Kalal S, et al. First detection of human parechovirus infection with diarrhoea, India. Infect Dis (Lond). 2017;49:151–152.
- Yamamoto SP, Kaida A, Naito T, et al. Human parechovirus infections and child myositis cases associated with genotype 3 in Osaka City, Japan, 2014. J Med Microbiol. 2015;64:1415–1424.
- Mardekian SK, Fortuna D, Nix A, et al. Severe human parechovirus type 3 myocarditis and encephalitis in an adolescent with hypogammaglobulinemia. Int J Infect Dis. 2015;36:6–e8.
- Mizuta K, Yamakawa T, Nagasawa H, et al. Epidemic myalgia associated with human parechovirus type 3 infection among adults occurs during an outbreak among children: findings from Yamagata, Japan, in 2011. J Clin Virol. 2013;58:188–193.
- Abed Y, Boivin G. Human parechovirus types 1, 2 and 3 infections in Canada. Emerging Infect Dis. 2006;12:969–975.
- Watanabe K, Oie M, Higuchi M, et al. Isolation and characterization of novel human parechovirus from clinical samples. Emerging Infect Dis. 2007;13:889–895.
- Mizuta K, Kuroda M, Kurimura M, et al. Epidemic myalgia in adults associated with human parechovirus type 3 Infection, Yamagata, Japan, 2008. Emerging Infect Dis. 2012;18:1787–1793.
- Esposito S, Rahamat-Langendoen J, Ascolese B, et al. Pediatric parechovirus infections. J Clin Virol. 2014;60:84–89.
- de Crom SCM, Obihara CC, de Moor RA, et al. Prospective comparison of the detection rates of human enterovirus and parechovirus RT-qPCR and viral culture in different pediatric specimens. J Clin Virol. 2013;58:449–454.